Exact Mass: 467.17663440000007
Exact Mass Matches: 467.17663440000007
Found 81 metabolites which its exact mass value is equals to given mass value 467.17663440000007
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
O-Ethyl-4-[(2',3',4'-tri-O-acetyl-alpha-L-rhamnosyloxy)benzyl]carbamate
C22H29NO10 (467.17913740000006)
O-Ethyl-4-[(2,3,4-tri-O-acetyl-alpha-L-rhamnosyloxy)benzyl]carbamate is a fully acetylated carbamate glycoside. It has been isolated from the leaves of Moringa oleifera (horseradish tree). It is found in fats and oils, herbs and spices, and green vegetables.
4-Hydroxytamoxifen sulfate
C26H29NO5S (467.17663440000007)
4-Hydroxytamoxifen sulfate is a metabolite of tamoxifen. Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. (Wikipedia)
Firuglipel
C25H26FN3O5 (467.18563980000005)
YM201636
Ala Cys Phe Gln
C20H29N5O6S (467.18384540000005)
Ala Cys Gln Phe
C20H29N5O6S (467.18384540000005)
Ala Phe Cys Gln
C20H29N5O6S (467.18384540000005)
Ala Phe Gln Cys
C20H29N5O6S (467.18384540000005)
Ala Gln Cys Phe
C20H29N5O6S (467.18384540000005)
Ala Gln Phe Cys
C20H29N5O6S (467.18384540000005)
Cys Ala Phe Gln
C20H29N5O6S (467.18384540000005)
Cys Ala Gln Phe
C20H29N5O6S (467.18384540000005)
Cys Phe Ala Gln
C20H29N5O6S (467.18384540000005)
Cys Phe Gln Ala
C20H29N5O6S (467.18384540000005)
Cys Gln Ala Phe
C20H29N5O6S (467.18384540000005)
Cys Gln Phe Ala
C20H29N5O6S (467.18384540000005)
Phe Ala Cys Gln
C20H29N5O6S (467.18384540000005)
Phe Ala Gln Cys
C20H29N5O6S (467.18384540000005)
Phe Cys Ala Gln
C20H29N5O6S (467.18384540000005)
Phe Cys Gln Ala
C20H29N5O6S (467.18384540000005)
Phe Gly Met Asn
C20H29N5O6S (467.18384540000005)
Phe Gly Asn Met
C20H29N5O6S (467.18384540000005)
Phe Met Gly Asn
C20H29N5O6S (467.18384540000005)
Phe Met Asn Gly
C20H29N5O6S (467.18384540000005)
Phe Asn Gly Met
C20H29N5O6S (467.18384540000005)
Phe Asn Met Gly
C20H29N5O6S (467.18384540000005)
Phe Gln Ala Cys
C20H29N5O6S (467.18384540000005)
Phe Gln Cys Ala
C20H29N5O6S (467.18384540000005)
Gly Phe Met Asn
C20H29N5O6S (467.18384540000005)
Gly Phe Asn Met
C20H29N5O6S (467.18384540000005)
Gly Met Phe Asn
C20H29N5O6S (467.18384540000005)
Gly Met Asn Phe
C20H29N5O6S (467.18384540000005)
Gly Asn Phe Met
C20H29N5O6S (467.18384540000005)
Gly Asn Met Phe
C20H29N5O6S (467.18384540000005)
Met Phe Gly Asn
C20H29N5O6S (467.18384540000005)
Met Phe Asn Gly
C20H29N5O6S (467.18384540000005)
Met Gly Phe Asn
C20H29N5O6S (467.18384540000005)
Met Gly Asn Phe
C20H29N5O6S (467.18384540000005)
Met Asn Phe Gly
C20H29N5O6S (467.18384540000005)
Met Asn Gly Phe
C20H29N5O6S (467.18384540000005)
Asn Phe Gly Met
C20H29N5O6S (467.18384540000005)
Asn Phe Met Gly
C20H29N5O6S (467.18384540000005)
Asn Gly Phe Met
C20H29N5O6S (467.18384540000005)
Asn Gly Met Phe
C20H29N5O6S (467.18384540000005)
Asn Met Phe Gly
C20H29N5O6S (467.18384540000005)
Asn Met Gly Phe
C20H29N5O6S (467.18384540000005)
Gln Ala Cys Phe
C20H29N5O6S (467.18384540000005)
Gln Ala Phe Cys
C20H29N5O6S (467.18384540000005)
Gln Cys Ala Phe
C20H29N5O6S (467.18384540000005)
Gln Cys Phe Ala
C20H29N5O6S (467.18384540000005)
Gln Phe Ala Cys
C20H29N5O6S (467.18384540000005)
Gln Phe Cys Ala
C20H29N5O6S (467.18384540000005)
6-hydroxydoxazosin
YM-201636
Bis-N-butyl phthalate
C22H29NO10 (467.17913740000006)
Citarinostat
C24H26ClN5O3 (467.17240760000004)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
3-[3-[(E)-[(2-hydroxy-2,2-diphenylacetyl)hydrazinylidene]methyl]-2,5-dimethylpyrrol-1-yl]benzoic acid
Ethyl 5-oxo-5-[(18-phenyl-11-oxa-13,15-diazatetracyclo[8.8.0.02,7.012,17]octadeca-1(10),2,4,6,8,12,14,16-octaen-16-yl)amino]pentanoate
2,2,2-trifluoro-N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C19H28F3N3O5S (467.1701674000001)
N-[(2R,4aR,12aS)-5-methyl-2-[2-(4-morpholinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]methanesulfonamide
C21H29N3O7S (467.17261240000005)
N-[(2R,4aS,12aR)-5-methyl-2-(2-morpholin-4-yl-2-oxoethyl)-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]methanesulfonamide
C21H29N3O7S (467.17261240000005)
N-[(2R,4aS,12aS)-5-methyl-2-[2-(4-morpholinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]methanesulfonamide
C21H29N3O7S (467.17261240000005)
2,2,2-trifluoro-N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C19H28F3N3O5S (467.1701674000001)
N-[(2S,4aR,12aS)-5-methyl-2-(2-morpholin-4-yl-2-oxoethyl)-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]methanesulfonamide
C21H29N3O7S (467.17261240000005)
N-[(2S,4aS,12aS)-5-methyl-2-(2-morpholin-4-yl-2-oxoethyl)-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]methanesulfonamide
C21H29N3O7S (467.17261240000005)
N-[(2R,4aR,12aR)-5-methyl-2-(2-morpholin-4-yl-2-oxoethyl)-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]methanesulfonamide
C21H29N3O7S (467.17261240000005)
2,2,2-trifluoro-N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C19H28F3N3O5S (467.1701674000001)
2,2,2-trifluoro-N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C19H28F3N3O5S (467.1701674000001)
N-[(2S,4aS,12aR)-5-methyl-2-[2-(4-morpholinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]methanesulfonamide
C21H29N3O7S (467.17261240000005)
2,2,2-trifluoro-N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C19H28F3N3O5S (467.1701674000001)
2,2,2-trifluoro-N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C19H28F3N3O5S (467.1701674000001)
N-[(2S,4aR,12aR)-5-methyl-2-[2-(4-morpholinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]methanesulfonamide
C21H29N3O7S (467.17261240000005)
(1S,5R)-3-(4-phenylphenyl)sulfonyl-7-(4-pyridin-4-ylphenyl)-3,6-diazabicyclo[3.1.1]heptane
(1R,5S)-7-[4-(3-methoxyphenyl)phenyl]-N-[4-(trifluoromethyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide
4,7-DI(Para-ethoxyphenyl)-6-(para-methylphenyl)-1,2,5-thiadiazolo(3,4-C)pyridine
[8-(aminomethyl)-2,5,12-trihydroxy-3,6-dimethyl-10-(2-sulfanylethyl)-3,7,8,10-tetrahydro-9,1,4,7,11-benzoxatetrazacyclotetradecin-6-yl]acetic acid
C20H29N5O6S (467.18384540000005)
n-[(4-{[3,4,5-tris(acetyloxy)-6-methyloxan-2-yl]oxy}phenyl)methyl]ethoxycarboximidic acid
C22H29NO10 (467.17913740000006)
n-[(4-{[(2s,3r,4r,5s,6s)-3,4,5-tris(acetyloxy)-6-methyloxan-2-yl]oxy}phenyl)methyl]ethoxycarboximidic acid
C22H29NO10 (467.17913740000006)